{
  "ptid_time": "037_S_4071_2013-08-02",
  "img_path": "/data/qiuhui/data/adni/images/037_S_4071/2013-08-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 111,888 mm³, 138.0% above the reference mean. With a Z-score of 4.01 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 7,154 mm³, 2.7% above the reference mean. With a Z-score of 0.23 (59.1th percentile), this represents normal volume ; whole brain volume measures 1,112,780 mm³, 8.1% above the reference mean. With a Z-score of 1.06 (85.6th percentile), this represents mild enlargement. ",
  "text_data": "Age is 86.5 years. Gender is Male. Education: 13 years. MMSE: 24.0. MoCA: 17.0. Logical Memory: 7.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 1008.00 pg/mL (normal ); Total tau: 418.90 pg/mL (significant elevated); Phosphorylated tau: 37.61 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows profound ventricular enlargement (Z-score 4.01), which is strongly suggestive of significant brain atrophy, particularly in the context of elevated T-tau and P-tau (indicative of neurodegeneration). Despite normal hippocampal volume, the cognitive scores (MMSE 24, MoCA 17) are below expected thresholds for normal cognition, aligning more with mild cognitive impairment (MCI) or early dementia. The absence of Aβ pathology suggests non-Alzheimer’s neurodegeneration (e.g., tauopathy or another dementia subtype).  \n\n**Diagnosis:** **Dementia** (likely non-AD subtype, given normal Aβ but elevated tau).  \n**Confidence:** **Medium** (high confidence in neurodegeneration due to imaging/biomarkers, but subtype uncertainty without further clinical history or FDG-PET/CSF data).",
  "timestamp": "2025-07-26T06:41:26.634419"
}